PMHSOTCPharmaceutical PreparationsFiscal year ends December 31
Polomar Health Services, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.12−0.01 (-4.00%)
Close on Oct 19, 2026
- Market cap
- $3.37M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0800 (−40.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Polomar Health Services, Inc. grew revenue 7688.8% to $3.17M over the twelve months to Jun 30, 2026.
Revenue
$3.17M
+7688.8% vs. a year earlier
Operating income
-$9.36M
TTM Q2 2026
EPS, diluted
-$0.34
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $3.37M
- P/E ratio
- –
- Price to sales
- 1.06
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $3.17M
- Net income
- -$9.46M
- EPS, diluted
- -$0.34
- Book value per share
- -$0.04
- Diluted shares
- 28M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
$3.17M+7688.8% YoY
Gross profit
$1.94M+7674.1% YoY
Operating income
-$9.36M
Net income
-$9.46M
EPS, diluted
-$0.34
Free cash flow
–
Reported periodTrailing twelve months